These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2725797)

  • 1. Clinical relevance of lysozyme in the faeces.
    Hemrika MH; Costongs GM; Engels LG; Bos LP; Janson PC; Flendrig JA
    Neth J Med; 1989 Apr; 34(3-4):174-81. PubMed ID: 2725797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lysozyme in children with acute and chronic inflammatory intestinal diseases].
    Dick W; Braun OH; Nagel W
    Padiatr Padol; 1985; 20(2):143-50. PubMed ID: 3991222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
    Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
    Lettesjö H; Hansson T; Peterson C; Ung KA; Ringström G; Abrahamsson H; Simrén M
    Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
    Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
    Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An initial report of sleep disturbance in inactive inflammatory bowel disease.
    Keefer L; Stepanski EJ; Ranjbaran Z; Benson LM; Keshavarzian A
    J Clin Sleep Med; 2006 Oct; 2(4):409-16. PubMed ID: 17557469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lysozyme in inflammatory bowel disease.
    Dobbins JW; Binder HJ; Spiro HM; Finch SC
    Gastroenterology; 1976 Mar; 70(3):469-71. PubMed ID: 1248707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lysozyme in the differential diagnosis of infections].
    Dick W
    Med Klin; 1981 May; 76(10):276-8. PubMed ID: 7231322
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzymes in feces: useful markers of chronic inflammatory bowel disease.
    Angriman I; Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Sturniolo GC; D'Amico DF; Plebani M
    Clin Chim Acta; 2007 May; 381(1):63-8. PubMed ID: 17368600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lysozyme levels in inflammatory bowel disease.
    Manier JW; Roberts RC; Zais DP
    Am J Gastroenterol; 1977 Mar; 67(3):245-8. PubMed ID: 868843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Serum lysozyme in inflammatory bowel disease.
    Belaiche J; Vesin P; Cattan D; Zittoun J; Bernier JJ
    Gastroenterology; 1976 Apr; 70(4):633-4. PubMed ID: 1254148
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory evaluation of inflammatory bowel disease.
    Wong A; Bass D
    Curr Opin Pediatr; 2008 Oct; 20(5):566-70. PubMed ID: 18781120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lysozyme: basic facts and diagnostic importance].
    Dick W
    Fortschr Med; 1982 Jul; 100(26):1230-4. PubMed ID: 7118031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
    Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and faecal lysozyme in inflammatory bowel disease.
    Klass HJ; Neale G
    Gut; 1978 Mar; 19(3):233-9. PubMed ID: 631644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.